TEKsystems · 2 hours ago
Epic Beacon Analyst
TEKsystems is a leading provider of business and technology services, helping clients activate ideas and solutions for transformation. They are seeking an Epic Beacon Analyst to build and maintain Epic Beacon protocols, support infusion scheduling, and collaborate with clinical teams to optimize workflows.
Information Technology
Responsibilities
Building and maintaining Epic Beacon protocols and therapy plans
Supporting infusion scheduling, including expansion into non‑oncology areas
Collaborating closely with clinical and operational teams to optimize treatment workflows
Assisting with Epic upgrades, including the November and February upgrades scheduled for May
Troubleshooting Beacon workflow and treatment plan issues
Using Epic Roundtable for protocol management (experience helpful, but they will teach it)
Qualification
Required
Strong experience with Epic Beacon (protocol & therapy plan build)
Hands-on Epic build experience
Ability to thrive in a fast‑paced environment and make immediate impact
Benefits
Medical, dental & vision
Critical Illness, Accident, and Hospital
401(k) Retirement Plan – Pre-tax and Roth post-tax contributions available
Life Insurance (Voluntary Life & AD&D for the employee and dependents)
Short and long-term disability
Health Spending Account (HSA)
Transportation benefits
Employee Assistance Program
Time Off/Leave (PTO, Vacation or Sick Leave)
Company
TEKsystems
At TEKsystems, they understand people. Every year they deploy over 80,000 IT professionals at 6,000 client sites across North America,
H1B Sponsorship
TEKsystems has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (46)
2024 (52)
2023 (33)
2022 (22)
2021 (36)
2020 (53)
Funding
Current Stage
Late StageRecent News
2025-11-19
2025-10-29
Company data provided by crunchbase